Drugs / Medical Radiation Protectants
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02729324 | Apr 2016 → Jun 2017 | nasopharyngeal neoplasm, radiodermatitis | Yun-fei Xia | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Medical Radiation Protectants | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02729324 ↗ |
| Known as | FORRAD | “Medical Radiation Protectants (FORRAD®) is prescribed at the beginning of radiotherapy for free.” NCT02729324 ↗ |
| Route | Topical | “Patients are asked to start topical application of Medical Radiation Protectants (FORRAD®) on irradiated skin at the onset of radiotherapy” NCT02729324 ↗ |